Innovations in Vaccine Development: Norway's Commitment to Global Health

Join us 3 September at Rikshospitalet for a seminar celebrating Richard Hatchett's honorary doctorate at UiO and highlighting Norway's commitment to groundbreaking strategies in vaccine development. The event will feature experts discussing innovative vaccine technologies and pandemic prepareness, revealing some critical advancements shaping our global health landscape.

Time and place: Sep. 3, 2024 2:00 PM – 4:00 PM, Runde Auditorium, Domus Medica

Add to calendar

A vaccine particle and a hand holding a syringe

Virus and vaccine. Illustration by WiR_Pixs at Pixabay.

Background

Dr. Richard Hatchett, CEO of the Coalition for Epidemic Preparedness Innovations (CEPI), is being awarded an honorary doctorate by the University of Oslo (UiO) in recognition of his outstanding contributions to global health and vaccine development. Under his leadership, CEPI has played a pivotal role in accelerating the development of vaccines against emerging infectious diseases, including the rapid response to the COVID-19 pandemic. This seminar will explore Norway's committment to advancements in vaccine technology, featuring talks from leading experts on mucosal vaccines and APC-targeted vaccines, offering a glimpse into the role vaccines play in pandemic preparedness.

Language

The event will be held in English

Please register the event

Program

Tuesday, September 3^rd, 14.00-16.00

14.00-14.15 Introduction

Speaker not yet confirmed

14.15-15.00 Richard Hatchett

CEPI strategy for developing vaccines against the next pandemic.

15.00-15.15 Break

15.15-15.45 Jan Terje Andersen

Mucosal vaccines for improved protection.

15.45-16.00 Gunnveig Grødeland

APC-targeted vaccines for rapid quenching of a new pandemic.

Published May 29, 2024 2:12 PM - Last modified June 18, 2024 10:12 AM